We further analyzed the association between RRBP1 and chemoresistant genes according to two important studies: (1) Mari et al. identified chemoresistance genes in bladder cancer [37]; and, recently, (2) Shriwas et al. found that RRBP1 contributes to the expression of YAP1 and influences cisplatin-based chemotherapy through the regulation of YAP1-mediated genes [38]. Here, YAP1 is linked to urinary bladder carcinoma.